What does this research mean for the field?

Nanoparticle-based drug delivery systems overcome the limitations of conventional dosage forms by improving drug stability, enhancing targeted delivery, and increasing therapeutic efficacy, despite remaining challenges in toxicity and mass production. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the fundamental principles, design strategies, and clinical utility of nanoparticle-based drug delivery systems across various therapeutic areas.

September 1, 2026World Journal of Pharmacy and Pharmaceutical SciencesOpen Access

Nanoparticles in Drug Delivery

View Full Paper

Ask AI

Bookmark

Authors

SRShubham Raj*1, Mrs. Jyoti Kumari2, Rajaram R. Rajbhar3

Discussion

Member takes

Implication

Comprehensive review demonstrates enhanced targeted drug delivery across diverse disease models, highlighting improved therapeutic efficacy and reduced off-target toxicity.

Key Points

To evaluate the fundamental principles, design strategies, and clinical utility of nanoparticle-based drug delivery systems across various therapeutic areas.
Synthesized literature on nanocarrier formulations, including polymeric nanoparticles, liposomes, solid lipid nanoparticles, dendrimers, and metallic carriers.
Evaluated release kinetics, targeting mechanisms, and applications across oncology, central nervous system disorders, cardiovascular diseases, and gene therapy.
Nanocarrier systems substantially improve therapeutic efficacy by enhancing drug solubility, protecting fragile payloads, and facilitating targeted tissue accumulation.
Key translational bottlenecks persist regarding nanotoxicity profiles, long-term physicochemical stability, and scalable manufacturing standards.

Cite This Study

Shubham Raj*1, Mrs. Jyoti Kumari2, Rajaram R. Rajbhar3 (2026) studied this question.

synapsesocial.com/papers/6a96914e7a497a6ca291f48e https://doi.org/10.5281/zenodo.22156779

View Full Paper

Ask AI

Bookmark

September 1, 2026World Journal of Pharmacy and Pharmaceutical SciencesOpen Access

Nanoparticles in Drug Delivery

View Full Paper

Ask AI

Bookmark

Authors

SRShubham Raj*1, Mrs. Jyoti Kumari2, Rajaram R. Rajbhar3

Discussion

Member takes

Implication

Comprehensive review demonstrates enhanced targeted drug delivery across diverse disease models, highlighting improved therapeutic efficacy and reduced off-target toxicity.

Key Points

To evaluate the fundamental principles, design strategies, and clinical utility of nanoparticle-based drug delivery systems across various therapeutic areas.
Synthesized literature on nanocarrier formulations, including polymeric nanoparticles, liposomes, solid lipid nanoparticles, dendrimers, and metallic carriers.
Evaluated release kinetics, targeting mechanisms, and applications across oncology, central nervous system disorders, cardiovascular diseases, and gene therapy.
Nanocarrier systems substantially improve therapeutic efficacy by enhancing drug solubility, protecting fragile payloads, and facilitating targeted tissue accumulation.
Key translational bottlenecks persist regarding nanotoxicity profiles, long-term physicochemical stability, and scalable manufacturing standards.

Cite This Study

Shubham Raj*1, Mrs. Jyoti Kumari2, Rajaram R. Rajbhar3 (2026) studied this question.

synapsesocial.com/papers/6a96914e7a497a6ca291f48e https://doi.org/10.5281/zenodo.22156779

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark